Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

« Previous 12345 Next »
Viewing Page 1 of 5 | Showing Results 1 - 5 of 21

A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum

This randomized phase III trial is studying how well combination chemotherapy works in treating young patients with newly diagnosed high-risk acute...

Brenda Wittman, M.D.
  • Alaska Research
  • Providence Alaska Medical Center

ONC AALL08B1-Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

This research trial studies a risk-based classification system for patients with newly diagnosed acute lymphoblastic leukemia. Gathering health...

Brenda Wittman, M.D.
  • Alaska Research
  • Providence Alaska Medical Center

A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T- Lymphoblastic Leukemia (T-ALL) and T- Lymphoblastic Lymphoma (T-LLy)

This randomized phase III trial compares how well combination chemotherapy works when given with or without bortezomib in treating patients with...

Brenda Wittman, M.D.
  • Alaska Research
  • Providence Alaska Medical Center

Treatment of Patients With Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-Lineage Lymphoblastic Lymphoma (B-LLy)

This partially randomized phase III trial studies different combinations of risk-adapted chemotherapy regimens and their side effects and comparing...

Brenda Wittman, M.D.
  • Alaska Research
  • Providence Alaska Medical Center

ONC TheraSphere-A Humanitarian Device Exemption Treatment Protocol of TheraSphere� For Treatment of Unresectable Hepatocellular Carcinoma

The purpose of this protocol is to provide TheraSphere treatment for patients with liver cancer who cannot be treated by surgery. The effect on the...

Chakri Inampudi, M.D.
  • Alaska Research
  • Providence Alaska Medical Center
« Previous 12345 Next »
Viewing Page 1 of 5 | Showing Results 1 - 5 of 21